UTokyo Innovation Platform
Tokyo, Tokyoutokyo-ipc.co.jp
Overview
UTokyo Innovation Platform Co., Ltd. (UTokyo IPC) was established in 2016 as the first venture capital firm wholly owned by the University of Tokyo. Their activities encompass investing through the IPC1 Fund and the AOI No. 1 Fund, and supporting early-stage academic startups through their 1stRound incubator program. UTokyo IPC also operates the DEEPTECH DIVE platform to support professionals in the deep tech realm.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Dodai | Apr 2026 | Series A | Co-investor |
| Storm Therapeutics | Apr 2026 | Series C | Co-investor |
| Visban Corporation | Feb 2026 | Series A Extension | Co-investor |
| CORE Biomedicine | Sep 2025 | Series A | Co-investor |
| Logomix Biotechnology, Inc. | Jul 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.